Trials / Terminated
TerminatedNCT03406533
Sedation Strategies for Diagnostic Bronchoscopy
The Effect and Safety of Different Sedation Strategies for Diagnostic Bronchoscopy
- Status
- Terminated
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 28 (actual)
- Sponsor
- Changhai Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
Diagnostic bronchoscopy is an invasive procedure performed to diagnose respiratory diseases. But pain has been complained by most of the patients receiving such procedures. Sedation or anesthesia was required by both of the patients and bronchoscopists. Unfortunately, no consensus has been made upon the sedation strategies. Multiple sedation approaches have been applied, such as midazolam and fentanyl, remifentanil and propofol, dexmedetomidine and propofol. The present study was designed to compare these protocols in sedation for diagnostic bronchoscopy.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Midazolam | Midazolam is used as a common medication for sedation in all groups. |
| DRUG | Dexmedetomidine | Dexmedetomidine is used for sedation in bronchoscopy with less impact on respiration. |
| DRUG | Remifentanil | Remifentanil is used for analgesia to prevent bronchoscopy induced cough. |
| DRUG | Fentanyl | Fentanyl is another opioid drug used for analgesia to prevent bronchoscopy induced cough. |
| DRUG | Propofol | Propofol is used for sedation with high efficacy but more side effect on respiration than dexmedetomidine. |
Timeline
- Start date
- 2018-02-01
- Primary completion
- 2018-03-30
- Completion
- 2018-03-31
- First posted
- 2018-01-23
- Last updated
- 2019-06-12
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT03406533. Inclusion in this directory is not an endorsement.